Noteworthy New Institutional 5% Ownership

(since Q4 reporting)

http://seekingalpha.com/article/434391-noteworthy-new-institutional-5-ownership?source=yahoo

biotech company Avanir Pharmaceuticals (AVNR) that develops therapeutic products for the treatment of central nervous systems disorders of high unmet medical need, in which Fidelity Investments filed SEC Form SC 13G/A indicating that it holds 13.61 million or 10.26% of outstanding shares, an increase from the 8.42 million shares it held at the end of Q4.

(Form SC 13G/A- Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions (Amendment)).